REVIEW PAPER
Hyperthermia in rheumatic diseases. A promising approach?
More details
Hide details
Submission date: 2018-07-17
Final revision date: 2018-09-18
Acceptance date: 2018-10-02
Online publication date: 2018-10-31
Publication date: 2018-10-31
Reumatologia 2018;56(5):316-320
KEYWORDS
TOPICS
ABSTRACT
Hyperthermia is a method applied in the treatment of many diseases, including rheumatic diseases. There are relatively few reports concerning the role of that method in the treatment of these diseases, and most studies have not been randomised. Hyperthermia includes directed application of thermal energy. The aim of that therapy is to overcome the body’s natural thermoregulation mechanism through application of external heat sources such as electromagnetic radiation of various frequencies, or ultrasound. Usually, temperatures are used within the 38.5–43° range. Hyperthermia can be applied as topical, regional, or systemic treatment (the latter is called hyperthermia of the whole body). In rheumatology, mainly the effect of hyperthermia on the immune system of the body is used. That effect depends on the type of hyperthermia and temperatures applied. Best documented are the effects of hyperthermia in fibromyalgia and ankylosing spondylitis.
REFERENCES (31)
1.
Neymann CA, Osborne SI. Artificial fever produced by high frequency currents: preliminary report. Illinois Med J 1929; 56: 199-203.
2.
Short CL, Bauer W. Treatment of rheumatoid arthritis with fever induced by diathermy. A follow-up study. JAMA 1935; 104: 2165-2168.
3.
Pallazzi M, Maluta S, Dall’Oglio S, et al. The role of hyperthermia in the battle against cancer. Tumori 2010; 96: 902-910.
4.
Van der Zee J. Heating the patient: a promising approach? Ann Oncol 2002; 13: 1173-1184.
5.
Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002; 43: 33-56.
6.
Tarner IH, Műller-Ladner U, Uhlemann C, Lange U. The effect of mild whole-body hyperthermia on systemic levels of TNF-αlpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis. Clin Rheumatol 2009; 28: 397-402.
7.
Schmidt KL, Simon E. Thermotherapy of pain, trauma and inflammatory and degenerative rheumatic diseases. In: Thermotherapy for neoplasia, inflammation and pain, Kosaka M, Sugahara T, Schmidt Kl et al. (eds.). Tokyo, Berlin, Heidelberg 2001: 527-539.
8.
Schmidt KL. Aktuelle Aspekte der Balneotherapie rheumatischer Erkrankungen. In: Balneologie, Medizinische Klimatologie bei rheumatischen Erkrankungen, Karagülle MZ, Gutenbrunner C, Karagülle O (eds.). ISMH Verlag, Törpin 2003: 49-58.
9.
Akyurekli D, Gerig LH, Raaphorst GP. Changes in muscle blood flow distribution during hyperthermia. Int J Hyperthermia 1997; 13: 481-496.
10.
Brosseau L, Yonge KA, Robinson V, et al. Thermotherapy for treatment of osteoarthritis. Cochrane Database Syst Rev 2003; 4: CD004522.
11.
Giombini A, Di Cesare A, Safran MR, et al. Short term effectiveness hyperthermia for supraspinatus tendinopathy in athletes. A short term randomized controlled study. Am J Sport Med 2007; 34: 1247-1253.
12.
Giombini A, Giovannini V, Di Cesare A, et al. Hyperthermia induced by microwave diathermy in the management of muscle tendon and injuries. Br Med Bull 2007; 83: 379-396.
13.
Leon SA, Sabell SO, Arastu HH, et al. Effects of hyperthermia on bone. II.Heating of bone in vivo and stimulation of bone growth. Int J Hyperthermia 1993; 9: 77-87.
14.
Markovic M. Short term hyperthermia prevents activation of proinflammatory genes in type B synoviocytes by blocking the activation of the transcription factor NF-B. EJIFCC 2007; 18: 121-125.
15.
Stuhlmeier KM. Short term hyperthermia prevents the activation of mitogen-activated protein kinase p38. Exp Gerontol 2009; 44: 406-412.
16.
Huang YH, Haegerstrand A, Frostegard J. Effects of in vitro hyperthermia on proliferative responses and lymphocyte activity. Clin Exp Immunol 1996; 103: 61-66.
17.
Kappel M, Diamant M, Hansen MB, et al. Effects of in vitro hyperthermia on the proliferative response of blood mononuclear subsets and detection of interleukin 1 and 6, tumor necrosis factor alpha and interferon-gamma. Immunology 1991; 73: 304-308.
18.
Kappel M, Stadeager C, Tvede N, et al. Effects of in vivo hyperthermia on natural killer cell activity, in vitro proliferative responses and blood mononuclear cell subpopulations. Clin Exp Immunol 1991; 84: 175-180.
19.
Sukenik S, Flusser D, Abu-Shakra M. The role of spa therapy in various rheumatic diseases. Rheum Dis North Am 1999; 25: 883-897.
20.
Lehmann JF, Warren CG, Scham SM. Therapeutic heat and cold. Clin Orthop 1974; 99: 207-245.
21.
Weinberger A, Fadilah R, Lev A, et al. Treatment of articular effusions with local deep microwave hyperthermia. Clin Rheumatol 1989; 8: 461-466.
22.
Otremski I, Erling G, Cohen Z, et al. The effect of hyperthermia (42.5°C) on zymosan-induced synovitis of the knee. Br J Rheumatol 1994; 33: 721-723.
23.
Brenner M, Braun C, Oster M, et al. Thermal signature analysis as a novel method for evaluating inflammatory arthritis activity. Ann Rheum Dis 2006; 65: 306-311.
24.
Xiao J, Yang Y, He ZZ, Liu J. Investigation on three-dimensional temperature field of human knee considering anatomical structure. Intern J Heat Mass Transf 2011; 54: 1851-1860.
25.
Schleenbecker H, Schmidt KL. Zur Wirkung einer iterativen milden Ganzkŏrper-Hypertermie auf den Fibromyalgie Schmerz. Phys Rehab Kur Med 1998; 8: 113-117.
26.
Brockow T, Wagner A, Franke A, et al. A randomized controlled trial on the effectiveness of mild water-filtered near infrared whole-body hyperthermia as an adjunct to a standard multimodal rehabilitation in the treatment of fibromyalgia. Clin J Pain 2007; 23: 67-75.
27.
Chrubasik S, Junck H, Zappe HA, et al. A survey on pain complaints and health care utilization in a German population. Eur J Anaesthesiol 1998; 15: 397-408.
28.
Zauner D, Quehenberger F, Hermann J, et al. Whole body hyperthermia treatment increases interleukin 10 and toll-like receptor 4 expression in patients with ankylosing spondylitis: a pilot study. Int J Hyperthermia 2014; 30: 393-401.
29.
Agrawal S. Effects of moderate whole-body hiperthermia and complementary medicine in the treatment of rheumatoid arthritis: a preliminary study. Oncothermia J 2018; 22: 8-19.
30.
Oosterveld FGJ, Koopman E, Scholtenhuis JO, et al. No adverse physiological response to infrared whole body hyperthermia in patients with rheumatoid arthritis and ankylosing spondylitis compared to healthy subjects. In: World Scientific and Engineering Academy and Society (ed.). Advances in biomedical research. University of Cambridge, February 23-25, 2010. WSEAS Press, 2010: 252-259.
31.
Romeyke T, Scheuer HC, Stummer H. Fibromyalgia with severe forms of progression in a multidisciplinary therapy setting with emphasis on hyperthermia therapy – a prospective controlled study. Clin Interv Aging 2014; 10: 69-79.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.